Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00047450 · ClinicalTrials.gov registry record · NA
Antidepressant Treatment in Older Adults With Schizophrenia
A NA study, sponsored by Veterans Medical Research Foundation.
- Completed
- Registry status
- NA
- Development phase
- 212
- Enrollment target
NCT00047450: Completed NA study, sponsored by Veterans Medical Research Foundation.
NCT00047450 is a NA study that has completed, run by Veterans Medical Research Foundation. The registered enrollment target is 212 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00047450, a NA study, has completed, sponsored by Veterans Medical Research Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 212 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of citalopram (Celexa) for the treatment of depressive symptoms in middle-aged and elderly patients with schizophrenia.
Interventions
- DRUG Placebo
- DRUG Citalopram (Celexa)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2001-09 |
| Est. Completion | 2007-09 |
| Phase | NA |
What the finished NCT00047450 record still lists
NCT00047450 is an interventional study that assigns participants to a tested intervention. The registered 212 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00047450 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00047450 about?
NCT00047450 is a clinical study titled "Antidepressant Treatment in Older Adults With Schizophrenia". The purpose of this study is to evaluate the safety and effectiveness of citalopram (Celexa) for the treatment of depressive symptoms in middle-aged and elderly patients with schizophrenia.
What is the current status of trial NCT00047450?
This trial is currently completed. It is a NA study. The enrollment target is 212 participants. The study started on 2001-09. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00047450?
The interventions under investigation include: Placebo (DRUG), Citalopram (Celexa) (DRUG).
Who is sponsoring clinical trial NCT00047450?
This trial is sponsored by Veterans Medical Research Foundation, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00047450's enrollment target sits among peer trials
212 489th of 2000 higher than 1,511 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
- NCT06456593 · 212 participants · Phase 2
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia